Identification of an Overabundant Cholesterol Precursor in Hepatitis B Virus Replicating Cells by Untargeted Lipid Metabolite Profiling-Reference-Cited by-同舟云学术

Identification of an Overabundant Cholesterol Precursor in Hepatitis B Virus Replicating Cells by Untargeted Lipid Metabolite Profiling

Published:2009-03-20 Issue:14 Volume:131 Page:5030-5031
ISSN:0002-7863
Container-title:Journal of the American Chemical Society
language:en
Short-container-title:J. Am. Chem. Soc.

Author:

Rodgers Mary A.¹,Saghatelian Alan¹,Yang Priscilla L.¹

Affiliation:

1. Department of Microbiology and Molecular Genetics, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts 02115, and Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, Massachusetts 02138

Publisher

American Chemical Society (ACS)

Subject

Colloid and Surface Chemistry,Biochemistry,General Chemistry,Catalysis

Link

https://pubs.acs.org/doi/pdf/10.1021/ja809949r

Reference24 articles.

1. Human immunodeficiency virus and host cell lipids. Interesting pathways in research for a new HIV therapy

2. Sphingomyelin and Cholesterol: From Membrane Biophysics and Rafts to Potential Medical Applications

3. Reliance of Host Cholesterol Metabolic Pathways for the Life Cycle of Hepatitis C Virus

4. Dynamics of the Cellular Metabolome during Human Cytomegalovirus Infection

5. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 7-Dehydrocholesterol dictates ferroptosis sensitivity;Nature;2024-01-31

2. Metabolomic profiling of Marek’s disease virus infection in host cell based on untargeted LC-MS;Frontiers in Microbiology;2023-11-09

3. Proteomic and metabonomic analysis uncovering Enterovirus A71 reprogramming host cell metabolic pathway;PROTEOMICS;2022-11-03

4. Dose–Response Effects of 7-Dehydrocholesterol Reductase Inhibitors on Sterol Profiles and Vesicular Stomatitis Virus Replication;ACS Pharmacology & Translational Science;2022-10-25

5. Atorvastatin Rapidly Reduces Hepatitis B Viral Load in Combination with Tenofovir: A Prospective Clinical Trial;Canadian Journal of Infectious Diseases and Medical Microbiology;2022-07-14